Medicum - Rilutek Fair PharmaCare Financial Assistance
The ALS Society of BC in collaboration with Sanofi Canada, the makers of RILUTEK, recognize that in some cases there may be certain patients diagnosed with ALS who qualify for drug benefit eligibility for their prescription of RILUTEK from BC Fair PharmaCare, but may not be able to start and/or maintain treatment as a result of upfront deductibles or applicable co-pays until they meet their Family Maximum. In order to help these patients to continue their prescribed treatment of RILUTEK, we are introducing the RILUTEK - Fair PharmaCare Financial Assistance program starting June 1, 2012.
For more information, contact France Martinelli, Toll-Free at Medicum Patient Assistance Program, the program’s special coordinator at 1-866-474-5883. You can find out more about Medicum on-line at www.medicum.ca.